TotalMarketCap

Market cap

$31.563 B

$84.63 -4.35%

Close of 6 Nov 2026

As of 6 Nov 2026, Dexcom (DXCM) has a market capitalization of $31.6B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.66B

#710 by revenue

Earnings

$836.3M

#441 by earnings

Shares outstanding

372,950,922

Latest filing cover page

P/E ratio

37.7

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #5MedlineMDLN$52.3B
  2. #6ResmedRMD$33.7B
  3. #7DexcomDXCM$31.6B
  4. #8West Pharmaceutical ServicesWST$27.4B
  5. #9SolventumSOLV$14.8B

What if Dexcom were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for Dexcom are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.